Susquehanna International Group, LLP Acadia Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $7.19 Million - $9.09 Million	474,700 Added 263.14%	655,100 $10.1 Million
Q2 2024 Aug 15, 2024	SELL	$14.62 - $18.42 $2.58 Million - $3.26 Million	-176,800 Reduced 49.5%	180,400 $2.93 Million
Q1 2024 May 07, 2024	BUY	$17.79 - $30.86 $3.72 Million - $6.46 Million	209,300 Added 141.51%	357,200 $6.6 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $1.45 Million - $2.22 Million	-69,800 Reduced 32.06%	147,900 $4.63 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $2.47 Million - $3.97 Million	118,600 Added 119.68%	217,700 $4.54 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $65,860 - $94,905	3,700 Added 3.88%	99,100 $2.37 Million
Q1 2023 May 16, 2023	BUY	$16.32 - $20.92 $310,080 - $397,480	19,000 Added 24.87%	95,400 $1.8 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $410,380 - $538,407	-28,900 Reduced 27.45%	76,400 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $3.03 Million - $3.92 Million	-214,800 Reduced 67.1%	105,300 $1.72 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $1.62 Million - $3.4 Million	-124,900 Reduced 28.07%	320,100 $4.51 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $4.16 Million - $5.46 Million	-198,500 Reduced 30.85%	445,000 $10.8 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $7.04 Million - $11.4 Million	419,000 Added 186.64%	643,500 $15 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $160,956 - $252,654	10,200 Added 4.76%	224,500 $3.73 Million
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $4.82 Million - $6.82 Million	-248,700 Reduced 53.71%	214,300 $5.23 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $5.76 Million - $12.7 Million	230,300 Added 98.97%	463,000 $11.9 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $2.04 Million - $2.83 Million	49,800 Added 27.23%	232,700 $12.4 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $4.49 Million - $7.03 Million	-123,400 Reduced 40.29%	182,900 $7.55 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $2.49 Million - $3.35 Million	63,500 Added 26.15%	306,300 $14.8 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $4.07 Million - $6.03 Million	-128,700 Reduced 34.64%	242,800 $10.3 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $5.31 Million - $7.54 Million	-146,700 Reduced 28.31%	371,500 $15.9 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $1.22 Million - $2.42 Million	55,000 Added 11.87%	518,200 $18.7 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $2.62 Million - $3.16 Million	-112,500 Reduced 19.54%	463,200 $12.4 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $5.25 Million - $8.89 Million	-324,800 Reduced 36.07%	575,700 $15.5 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $213,368 - $341,508	-14,900 Reduced 1.63%	900,500 $14.6 Million
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $8.05 Million - $13.5 Million	617,800 Added 207.59%	915,400 $19 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $5.66 Million - $8.39 Million	-375,600 Reduced 55.79%	297,600 $4.55 Million
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $9.96 Million - $14.3 Million	443,100 Added 192.57%	673,200 $15.1 Million
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $5.35 Million - $7.8 Million	-199,200 Reduced 46.4%	230,100 $6.93 Million
Q3 2017 Nov 20, 2017	BUY	$29.49 - $38.37 $12.7 Million - $16.5 Million	429,300	429,300 $16.2 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account